These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 12569967)

  • 41. Botulinum toxin A injection for spasticity in diplegic-type cerebral palsy.
    El O; Peker O; Kosay C; Iyilikci L; Bozan O; Berk H
    J Child Neurol; 2006 Dec; 21(12):1009-12. PubMed ID: 17156689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection.
    Park ES; Park CI; Kim DY; Kim YR
    Arch Phys Med Rehabil; 2002 Nov; 83(11):1592-6. PubMed ID: 12422331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
    Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.
    Ade-Hall RA; Moore AP
    Cochrane Database Syst Rev; 2000; (2):CD001408. PubMed ID: 10796784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intrafusal effects of botulinum toxin injections for spasticity: revisiting a previous paper.
    Phadke CP; On AY; Kirazli Y; Ismail F; Boulias C
    Neurosci Lett; 2013 Apr; 541():20-3. PubMed ID: 23458671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
    Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C;
    N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.
    Teasell R; Foley N; Pereira S; Sequeira K; Miller T
    Top Stroke Rehabil; 2012; 19(2):115-21. PubMed ID: 22436359
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Has botulinum toxin type A a place in the treatment of spasticity in spinal cord injury patients?
    Al-Khodairy AT; Gobelet C; Rossier AB
    Spinal Cord; 1998 Dec; 36(12):854-8. PubMed ID: 9881735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of Injection-Guiding Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Focal Spasticity and Dystonia: A Systematic Review.
    Grigoriu AI; Dinomais M; Rémy-Néris O; Brochard S
    Arch Phys Med Rehabil; 2015 Nov; 96(11):2067-78.e1. PubMed ID: 25982240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
    Carraro E; Trevisi E; Martinuzzi A
    Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J; Hoare B; Wallen M
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
    Fève A; Decq P; Filipetti P; Kéravel Y
    Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Botulinum therapy of spastic forms of cerebral palsy in various locomotor patterns].
    Krasavina DA; Chemeris AV; Orlova OR; Ivanov YI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(6):119-123. PubMed ID: 34283541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potentiation of botulinum toxin type A with oral anti-spasticity medications in the management of focal spasticity.
    Dai A
    J Rehabil Med; 2007 Mar; 39(2):189; author reply 189. PubMed ID: 17351705
    [No Abstract]   [Full Text] [Related]  

  • 55. The use of botulinum toxin therapy for lower-extremity spasticity in children with cerebral palsy.
    Criswell SR; Crowner BE; Racette BA
    Neurosurg Focus; 2006 Aug; 21(2):e1. PubMed ID: 16918222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity.
    Kaku M; Simpson DM
    Drug Des Devel Ther; 2016; 10():1085-99. PubMed ID: 27022247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Botulinum toxin in the management of childhood muscle spasticity: comparison of clinical practice of 17 treatment centres.
    Bakheit AM
    Eur J Neurol; 2003 Jul; 10(4):415-9. PubMed ID: 12823494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
    Nott MT; Barden HL; Baguley IJ
    J Rehabil Med; 2014 Oct; 46(9):864-8. PubMed ID: 25074437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of motor end plate-targeted Botulinum toxin type A injections in children with cerebral palsyitle.
    Van Campenhout A; Bar-On L; Desloovere K; Molenaers G
    Acta Orthop Belg; 2015 Jun; 81(2):167-71. PubMed ID: 26280952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical trials of botulinum toxin in the treatment of spasticity.
    Simpson DM
    Muscle Nerve Suppl; 1997; 6():S169-75. PubMed ID: 9826988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.